Rosette inhibition test in chronic liver disease.
AUTOR(ES)
Salerno, F
RESUMO
A role has recently been assigned to cell-mediated immunity in chronic liver diseases in addition to the well-known alterations of humoral immunity. We now report the results of the rosette inhibition test for the evaluation of T-lymphocyte "sensitization" in patients with different chronic liver disorders. A cell-mediated immune reaction was found in 81% of patients with chronic active hepatitis and in 71% with primary biliary cirrhosis, whereas patients with chronic persistent hepatitis showed no reaction. The correlation with the incidence of hepatitis B antigen showed that T-lymphocyte sensitization was more frequent in the group of HB-positive patients. Finally, improvement of the test was observed in four out of nine patients given immunosuppressive treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=476178Documentos Relacionados
- Syphilis and chronic liver disease.
- ELECTROPHORETIC STUDIES IN LIVER DISEASE. II. GAMMA1 GLOBULIN IN CHRONIC LIVER DISEASE 12
- Immunomorphological characterisation of antinuclear antibodies in chronic liver disease.
- Galactose tolerance test of liver function in pulmonary heart disease.
- Portal lymphadenopathy associated with lipofuscin in chronic cholestatic liver disease.
